N-α-Boc-D-Arginine hydrochloride monohydrate

N-α-Boc-D-Arginine hydrochloride monohydrate is a D-configured arginine derivative bearing an α-amino group protected as a Boc carbamate and present as a hydrochloride salt with one molecule of water of crystallization. The side chain contains a guanidinium functionality that is strongly basic and can be tuned for reactivity through salt formation and subsequent protection/deprotection logic. The compound's stereogenic α-carbon and the Boc-protected amine make it a chiral amino acid intermediate with predictable peptide-coupling behavior under standard amide-forming conditions. The combination of a protected backbone and a salt-stabilized guanidine group supports controlled transformations in peptide synthesis, biochemical labeling, and downstream functionalization to generate arginine-containing scaffolds.

1. Peptide Synthesis

N-α-Boc-D-Arginine hydrochloride monohydrate is used in peptide synthesis as a protected arginine building block where the Boc carbamate masks the α-amino group for selective coupling at the N-terminus. The D-stereochemistry at the α-carbon provides stereochemical control for incorporating D-arginine motifs into peptides, including protease-resistant sequences and stereochemically defined analogs. The guanidinium side chain, present under hydrochloride conditions, can participate in salt-stabilized handling and can be carried through coupling steps without uncontrolled side reactions typical of unprotected amines. The resulting Boc-protected amino acid can be converted into peptide bonds and then deprotected to furnish arginine residues for subsequent peptide elongation or for generating arginine-rich fragments used in biochemical research.

2. Protected Amino Acids

N-α-Boc-D-Arginine hydrochloride monohydrate functions as a protected amino acid intermediate for orthogonal protection strategies that separate backbone N-protection from side-chain guanidinium reactivity. The Boc group enables N-deprotection under conditions compatible with many peptide synthesis workflows, while the guanidinium moiety can be managed as a salt form to maintain solubility and minimize undesired nucleophilicity during intermediate handling. The hydrochloride monohydrate form influences protonation state and can support reproducible coupling or derivatization planning when preparing libraries of protected amino acid derivatives. Downstream, the compound supports fine chemical synthesis of N-protected arginine derivatives, including intermediates used to assemble peptide conjugates, peptidomimetics, and stereochemically defined amino acid sequences.

3. Bioconjugation Chemistry

N-α-Boc-D-Arginine hydrochloride monohydrate is applicable to bioconjugation workflows that require incorporation of arginine-containing motifs for electrostatic interaction, affinity tuning, or linker design. The guanidinium side chain provides a strongly cationic handle that can be leveraged for constructing cell-penetrating peptide segments, affinity-tag mimics, or binding elements in chemical biology probes. Boc protection supports stepwise synthesis of conjugation-ready peptide fragments, allowing controlled deprotection and subsequent coupling to activated esters, activated acids, or other electrophiles used in conjugation chemistry. The D-configuration can be used to generate stereochemically defined conjugates that maintain arginine charge characteristics while altering protease susceptibility in downstream applications.

4. Peptidomimetics And SAR Studies

N-α-Boc-D-Arginine hydrochloride monohydrate serves in peptidomimetic and structure-activity relationship studies where arginine charge distribution and stereochemistry are key determinants of molecular recognition. The protected α-amino group supports assembly of arginine-containing analogs with defined backbone stereocenters, enabling systematic variation of peptide-like scaffolds while preserving guanidinium-mediated interactions. Boc deprotection and subsequent functional group transformations can be planned to generate analogs with altered N-terminal presentation, improved stability, or modified side-chain accessibility. The compound's chiral nature makes it suitable for preparing stereochemically consistent libraries used to probe binding modes, develop SAR datasets, and support fragment-to-lead optimization in applied medicinal chemistry settings.

5. Pharmaceutical Manufacturing Intermediates

N-α-Boc-D-Arginine hydrochloride monohydrate is relevant to pharmaceutical manufacturing as a chiral amino acid intermediate for producing arginine-containing peptide intermediates and peptide-like active ingredients or process intermediates. The Boc-protected backbone aligns with common industrial peptide synthesis protection schemes, where N-protection enables controlled coupling and later deprotection to reach the desired free amino functionality. The guanidinium group, managed in hydrochloride form, supports handling and can be carried through manufacturing steps that require reproducible salt-state behavior and minimized side reactions. Downstream synthetic utility includes conversion into higher-order building blocks, preparation of peptide fragments for further assembly, and support of process chemistry routes that require stereochemically defined D-arginine incorporation.

6. Analytical Standards And Labeling

N-α-Boc-D-Arginine hydrochloride monohydrate can be used to prepare analytical standards and reference materials for method development in amino acid analysis, peptide profiling, and stereochemical verification. The combination of Boc protection and D-configuration provides a defined chemical identity that can support calibration strategies for LC-MS or chromatographic workflows when monitoring protected amino acid intermediates and peptide fragments. The guanidinium functionality enables derivatization approaches that can enhance detection or support targeted mass spectrometric transitions for arginine-containing species. The compound also serves as a starting point for labeling and derivatization of arginine motifs in biochemical research intermediate preparation, supporting consistent comparison across synthetic batches and analytical method qualification.

1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

4. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

5. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I